{
  "ticker": "REGN",
  "year": 2022,
  "quarter": 1,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 6,
  "transactions": [
    {
      "id": 20266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-02-18",
      "transaction_shares": "335",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52795"
    },
    {
      "id": 40220,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-02-18",
      "transaction_shares": "335",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52795"
    },
    {
      "id": 72270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-02-18",
      "transaction_shares": "335",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52795"
    },
    {
      "id": 113180,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-02-18",
      "transaction_shares": "335",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52795"
    },
    {
      "id": 160181,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-02-18",
      "transaction_shares": "335",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52795"
    },
    {
      "id": 214360,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2022-02-18",
      "transaction_shares": "335",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52795"
    }
  ]
}